Clinical trial
The Efficacy of Mapping for Cognitive Prostate Biopsy: a Prospective, Randomized Study
NCT05902637 is registered in ClinicalTrials.gov with Marmara University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of Mapping for Cognitive Prostate Biopsy: a Prospective, Randomized Study
- Lead sponsor
- Marmara University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 1, 2023
- Completion date
- December 1, 2024
- Enrollment
- 175 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate adenocarcinoma, prostate cancer, prostate cancer stage, prostate disease, prostatic neoplasms